Literature DB >> 7723770

Preparation and characterization of a disulfide-stabilized Fv fragment of the anti-Tac antibody: comparison with its single-chain analog.

K O Webber1, Y Reiter, U Brinkmann, R Kreitman, I Pastan.   

Abstract

Recombinant DNA techniques now allow the production of "mini-antibodies" called Fv fragments. These have been produced either as the independent variable domains of the heavy and light chains non-covalently associated in one-to-one stoichiometry or as single-chain gene products with the two domains linked by an intervening peptide sequence. Although Fv fragments can have excellent binding properties, they are often difficult to produce in good yield and lack the characteristic stability of whole antibodies. To improve the stability of the Fv molecule, we have introduced a cysteine residue into conserved framework regions of both the heavy and light variable domains from the anti-Tac antibody at positions compatible with the formation of an interdomain disulfide linkage (i.e. VH-44 and VL-99). The mutant subunits form a disulfide-bonded Fv molecule, which binds to the alpha-subunit of the IL2 receptor (IL2R alpha) with an affinity identical to that of humanized anti-Tac IgG. This disulfide-stabilized Fv (dsFv) proved to be substantially more resistant to denaturation by heat or urea treatment than the single-chain Fv (scFv). Furthermore, the yield of dsFv is -four-fold higher than that of the single-chain analog.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7723770     DOI: 10.1016/0161-5890(94)00150-y

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

Review 1.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

2.  World Bispecific Antibody Summit, September 27-28, 2011, Boston, MA.

Authors:  Eugen Dhimolea; Janice M Reichert
Journal:  MAbs       Date:  2012 Jan-Feb       Impact factor: 5.857

3.  Development of tetravalent, bispecific CCR5 antibodies with antiviral activity against CCR5 monoclonal antibody-resistant HIV-1 strains.

Authors:  Jürgen Schanzer; Andreas Jekle; Junichi Nezu; Adriane Lochner; Rebecca Croasdale; Marianna Dioszegi; Jun Zhang; Eike Hoffmann; Wilma Dormeyer; Jan Stracke; Wolfgang Schäfer; Changhua Ji; Gabrielle Heilek; Nick Cammack; Michael Brandt; Pablo Umana; Ulrich Brinkmann
Journal:  Antimicrob Agents Chemother       Date:  2011-02-07       Impact factor: 5.191

4.  Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications.

Authors:  Tove Olafsen; Chia-Wei Cheung; Paul J Yazaki; Lin Li; Gobalakrishnan Sundaresan; Sanjiv S Gambhir; Mark A Sherman; Lawrence E Williams; John E Shively; Andrew A Raubitschek; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2004-01       Impact factor: 1.650

Review 5.  Antibody Fragments as Probe in Biosensor Development.

Authors:  Dirk Saerens; Lieven Huang; Kristien Bonroy; Serge Muyldermans
Journal:  Sensors (Basel)       Date:  2008-08-08       Impact factor: 3.576

Review 6.  Engineered hapten-binding antibody derivatives for modulation of pharmacokinetic properties of small molecules and targeted payload delivery.

Authors:  Stefan Dengl; Claudio Sustmann; Ulrich Brinkmann
Journal:  Immunol Rev       Date:  2016-03       Impact factor: 12.988

7.  Screening of human antibody Fab fragment against HBsAg and the construction of its dsFv form.

Authors:  Leili Jia; Jiyun Yu; Hongbin Song; Xuelin Liu; Weina Ma; Yuanyong Xu; Chuanfu Zhang; Shicun Dong; Qiao Li
Journal:  Int J Biol Sci       Date:  2008-04-24       Impact factor: 6.580

8.  Epitope blocking: positive and negative effects on the biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment of two antibodies against different epitopes of the circulating antigen.

Authors:  H Kobayashi; B F Sun; E S Han; M K Kim; N Le; Q C Wang; D L Nelson; I Pastan; T A Waldmann; C H Paik; J A Carrasquillo
Journal:  Jpn J Cancer Res       Date:  1998-04

9.  Digital PCR for high sensitivity viral detection in false-negative SARS-CoV-2 patients.

Authors:  Paolo Poggio; Paola Songia; Chiara Vavassori; Veronica Ricci; Cristina Banfi; Silvia Stella Barbieri; Gloria Garoffolo; Veronika A Myasoedova; Luca Piacentini; Angela Raucci; Alessandro Scopece; Elena Sommariva; Maria Cristina Vinci; Davide Carcione; Maria Luisa Biondi; Maria Elisabetta Mancini; Alberto Formenti; Daniele Andreini; Emilio M Assanelli; Piergiuseppe Agostoni; Marina Camera; Gualtiero I Colombo; Maurizio Pesce
Journal:  Sci Rep       Date:  2021-02-22       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.